We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Disc Replacement Holds Advantages Over Standard Fusion Surgery

By HospiMedica International staff writers
Posted on 04 Apr 2011
Two new studies suggest that for patients with back and neck pain, especially when several discs are involved, artificial disc replacement may give better long-term results than standard fusion surgery, and at a lower cost. More...


Researchers at the Cedars-Sinai Medical Center (Los Angeles, CA, USA) reviewed 209 patients with damaged cervical discs who received either minimally invasive disc replacement or complex spinal fusion surgery; these patients were followed at regular intervals for four years; a separate group of 136 patients who received an artificial disc two years after the first group were also part of this study. All patients were assessed on their satisfaction with the results of the procedure. The second study focused on 53 patients suffering from three-level, lumbar disc disease and looked at cost comparisons for length of hospital stay, resources used, and other factors.

The results showed that four years after surgery, nearly 88% of disc replacement patients reported that they were very to completely satisfied, compared with 76% of fusion patients. Improvements were seen in both flexibility and range of motion; physical and neurological improvement; and in self-assessed neck disability, and neck and arm pain intensity. These improvements were seen irrespective of the surgical procedure, but results tended to be at least slightly better in patients with disc replacements. An important finding was that four years out from surgery, fusion patients were four times more likely to need more surgery, with half of these secondary operations needed to treat new disc problems occurring adjacent to fused sections. Both studies were published in December 2010 issue of the SAS Journal.

"While the results of this 13-center study are preliminary, it appears that artificial disc replacement surgery compares favorably as an effective procedure, is preferred by patients and slows the rate of adjacent-level disease,” said lead author of both studies orthopedic surgeon Rick Delamarter, MD, codirector of the Cedars-Sinai Spine Center. "After safety and effectiveness of a procedure have been documented, cost is an important consideration; artificial disc replacement technology appears to offer a promising, cost-saving alternative to fusion, especially for patients with disease at three levels.”

Related Links:

Cedars-Sinai medical Center



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.